Intraoperative TIVA With Propofol on Postoperative Pain and Side Effects After Liver Resection Surgery

Sponsor
The University of Hong Kong (Other)
Overall Status
Unknown status
CT.gov ID
NCT02179437
Collaborator
(none)
1,000
1
8
125.3

Study Details

Study Description

Brief Summary

Postoperative pain can be severe after liver resection surgery. However, postoperative pain management may be difficult for this group of patients. Opioidergic neurotransmission may be altered in cirrhotic patients and selectively increasing receptor affinity for opioids. Large dose of strong opioid may be required to achieve adequate pain control. However, this may not be possible due to the side effect of opioid and liver dysfunction after liver resection.

Propofol is a commonly used anaesthetic with rapid recovery and less side effects and TIVA (total intravenous analgesia) with propofol is a common technique now. The reduction on certain serum pro- inflammatory cytokines may lead to more smooth post- surgical recovery.

Recent case report proved the analgesic effect of propofol infusion. However other animal and clinical studies showed controversial result.

The aim of this retrospective study is to investigate the postoperative analgesic effects and side effects of intraoperative TIVA with propofol in patient undergoing liver resection surgery at Queen Mary Hospital, Hong Kong between 2010 to 2012.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Retrospective audit.

    Anaesthetic records and acute pain service records of patient undergone liver resection surgery between 2010 to 2012 in Queen Mary Hospital would be retrieved from the computer.

    Data Collection

    1. Demographic data;

    2. Types of analgesic techniques;

    3. Type of pain relief modalities;

    4. Pain score up to 72 hours postoperatively;

    5. Postoperative opioid consumption;

    6. Incidence of adverse events during APS care;

    7. Patients' satisfaction on pain relief.

    Data Analysis For summarising analysis, mean or median with standard deviation or interquartile range will be reported. Parametric and non-parametric comparative tests will be used for analysis between/among patients with various characteristics. Kaplan Meier survival analysis and log-rank test will be used for duration of APS use.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1000 participants
    Time Perspective:
    Retrospective
    Official Title:
    Retrospective Study to Investigate Intraoperative TIVA With Propofol on Postoperative Pain and Side Effects After Liver Resection Surgery
    Study Start Date :
    Jul 1, 2014
    Anticipated Primary Completion Date :
    Jan 1, 2015
    Anticipated Study Completion Date :
    Mar 1, 2015

    Outcome Measures

    Primary Outcome Measures

    1. Postoperative pain score [From postoperative 1 hour to postoperative 72 hour]

    Secondary Outcome Measures

    1. Adverse event [From postoperative 1 hour to postoperative 72 hour]

    Other Outcome Measures

    1. Analgesic consumption [From postoperative 1 hour to postoperative 72 hour]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient undergone liver resection surgery between 2010 to 2012 in Queen Mary Hospital
    Exclusion Criteria:
    • Essential data were missing.

    • Patient participating in other research projects.

    • Changes in postoperative pain management technique.

    • Patients could not be assessed post-operatively for pain (i.e. post-operative IPPV)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Anaesthesiology, The University of Hong Kong Hong Kong Hong Kong China

    Sponsors and Collaborators

    • The University of Hong Kong

    Investigators

    • Principal Investigator: Chi Wai Cheung, MD, Department of Anaesthesiology, The University of Hong Kong

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Cheung Chi Wai, Clinical Associate Professor, The University of Hong Kong
    ClinicalTrials.gov Identifier:
    NCT02179437
    Other Study ID Numbers:
    • UW14-356
    First Posted:
    Jul 1, 2014
    Last Update Posted:
    Jul 1, 2014
    Last Verified:
    Jun 1, 2014
    Keywords provided by Cheung Chi Wai, Clinical Associate Professor, The University of Hong Kong
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 1, 2014